TABLE 3.
Metal | Mean EC50 (μM) ± SD (RI)b |
||
---|---|---|---|
pUCNEO | LABCG2 | LABCG2rev 90D | |
SbIII | 6.16 ± 0.07 | 21.30 ± 0.81 (3.4)* | 5.90 ± 0.11 (0.9) |
SbV | 76.14 ± 2.88 | >200 (>2.6)* | 87.73 ± 9.71 (1.1) |
Macrophage-differentiated THP-1 cells infected with L. major lines using a macrophage/parasite ratio of 1:10 were incubated for 3 days in the presence of SbIII or for 5 days in the presence of SbV at different concentrations, as described in Materials and Methods. Antimony susceptibility was determined from the percentage of infected cells and the number of intracellular amastigotes per cell in antimony-treated cultures versus nontreated cultures. Infection was determined by DAPI staining of 300 macrophages/well.
Resistance indexes (RI) were calculated by dividing the EC50 for the Leishmania line overexpressing LABCG2 and LABCG2rev 90D by that for the Leishmania control line (pUCNEO). Data are the means ± standard deviations of results from two independent experiments. Significant differences were determined by using the Student t test (*, P < 0.01).